Get real time updates directly on you device, subscribe now.
After the company Pfizer Inc announced on Wednesday that the Covid vaccine it developed with BioNTech showed 95% efficacy in the final phase 3 trial, BioNTech CEO Ugur Sahin told Reuters that the Vaccine deliveries could start before Christmas.
Featured statements:
“If all goes well, you could imagine we get approval in the second half of December and start deliveries before Christmasbut really only if everything goes well. ”
“The US emergency use authorization would be requested on Friday.”
Related Posts
.
